Boothbay Fund Management’s Amicus Therapeutics FOLD Stock Holding History

Boothbay Fund Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-204,500	Closed	-$1.95M	–	1975
2021 Q3	$1.95M	Buy	+204,500	New	+$2.09M	0.05%	456
2017 Q4	–	Sell	-653	Closed	-$985K	–	742
2017 Q3	$985K	Buy	+653	New	+$8.64K	0.16%	146

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Boothbay Fund Management's FOLD Position: Q2 2026 in Review

Boothbay Fund Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 28,472 shares — an estimated $412K sold.

Boothbay Fund Management first reported a position in FOLD in Q1 2021 and held it in 8 quarters. The position peaked at $3.33M in Q4 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Boothbay Fund Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Boothbay Fund Management sold 28,472 Amicus Therapeutics shares in Q2 2026, an estimated $412K.
Boothbay Fund Management first reported a position in Amicus Therapeutics in Q1 2021 and held it in 8 quarters.
Boothbay Fund Management's Amicus Therapeutics position peaked at $3.33M in Q4 2025.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.